The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders
The basal forebrain cholinergic nuclei (BFCN) provide the main cholinergic input to prefrontal cortices, the hippocampi, and amygdala. These structures are highly relevant for the regulation and maintenance of many cognitive functions, such as attention and memory. In vivo neuroimaging studies repor...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.909961/full |
_version_ | 1818118097921376256 |
---|---|
author | Sofia Eickhoff Leon Franzen Alexandra Korda Helena Rogg Valerie-Noelle Trulley Stefan Borgwardt Mihai Avram |
author_facet | Sofia Eickhoff Leon Franzen Alexandra Korda Helena Rogg Valerie-Noelle Trulley Stefan Borgwardt Mihai Avram |
author_sort | Sofia Eickhoff |
collection | DOAJ |
description | The basal forebrain cholinergic nuclei (BFCN) provide the main cholinergic input to prefrontal cortices, the hippocampi, and amygdala. These structures are highly relevant for the regulation and maintenance of many cognitive functions, such as attention and memory. In vivo neuroimaging studies reported alterations of the cholinergic system in psychotic disorders. Particularly, a downregulation of nicotinic and muscarinic acetylcholine receptors has been found. Crucially, such alterations in neurotransmission have been associated with cognitive impairments and positive and negative symptoms. Recent pharmacological studies support these findings, as they demonstrated an association between the manipulation of cholinergic transmission and an attenuation in symptom severity. Targeting acetylcholine receptors has therefore become a focus for the development of novel psychopharmacological drugs. However, many open questions remain. For instance, it remains elusive what causes such alterations in neurotransmission. While evidence supports the idea that BFCN structural integrity is altered in schizophrenia, it remains to be determined whether this is also present in other psychotic disorders. Furthermore, it is unclear when throughout the course of the disorder these alterations make their appearance and whether they reflect changes in the BFCN alone or rather aberrant interactions between the BFCN and other brain areas. In this review, the specific role of the BFCN and their projections are discussed from a neuroimaging perspective and with a focus on psychotic disorders alongside future directions. These directions set the stage for the development of new treatment targets for psychotic disorders. |
first_indexed | 2024-12-11T04:48:54Z |
format | Article |
id | doaj.art-5133a8efbc494186afe253443fae3860 |
institution | Directory Open Access Journal |
issn | 1664-0640 |
language | English |
last_indexed | 2024-12-11T04:48:54Z |
publishDate | 2022-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Psychiatry |
spelling | doaj.art-5133a8efbc494186afe253443fae38602022-12-22T01:20:27ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402022-07-011310.3389/fpsyt.2022.909961909961The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic DisordersSofia EickhoffLeon FranzenAlexandra KordaHelena RoggValerie-Noelle TrulleyStefan BorgwardtMihai AvramThe basal forebrain cholinergic nuclei (BFCN) provide the main cholinergic input to prefrontal cortices, the hippocampi, and amygdala. These structures are highly relevant for the regulation and maintenance of many cognitive functions, such as attention and memory. In vivo neuroimaging studies reported alterations of the cholinergic system in psychotic disorders. Particularly, a downregulation of nicotinic and muscarinic acetylcholine receptors has been found. Crucially, such alterations in neurotransmission have been associated with cognitive impairments and positive and negative symptoms. Recent pharmacological studies support these findings, as they demonstrated an association between the manipulation of cholinergic transmission and an attenuation in symptom severity. Targeting acetylcholine receptors has therefore become a focus for the development of novel psychopharmacological drugs. However, many open questions remain. For instance, it remains elusive what causes such alterations in neurotransmission. While evidence supports the idea that BFCN structural integrity is altered in schizophrenia, it remains to be determined whether this is also present in other psychotic disorders. Furthermore, it is unclear when throughout the course of the disorder these alterations make their appearance and whether they reflect changes in the BFCN alone or rather aberrant interactions between the BFCN and other brain areas. In this review, the specific role of the BFCN and their projections are discussed from a neuroimaging perspective and with a focus on psychotic disorders alongside future directions. These directions set the stage for the development of new treatment targets for psychotic disorders.https://www.frontiersin.org/articles/10.3389/fpsyt.2022.909961/fullbasal forebrain cholinergic nuclei (BFCN)psychotic disorders (incl schizophrenia)neuroimagingacetylcholine (ACh)muscarinic acetylcholine receptor (mAChR)nicotine acetylcholine receptor (nAChR) |
spellingShingle | Sofia Eickhoff Leon Franzen Alexandra Korda Helena Rogg Valerie-Noelle Trulley Stefan Borgwardt Mihai Avram The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders Frontiers in Psychiatry basal forebrain cholinergic nuclei (BFCN) psychotic disorders (incl schizophrenia) neuroimaging acetylcholine (ACh) muscarinic acetylcholine receptor (mAChR) nicotine acetylcholine receptor (nAChR) |
title | The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders |
title_full | The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders |
title_fullStr | The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders |
title_full_unstemmed | The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders |
title_short | The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders |
title_sort | basal forebrain cholinergic nuclei and their relevance to schizophrenia and other psychotic disorders |
topic | basal forebrain cholinergic nuclei (BFCN) psychotic disorders (incl schizophrenia) neuroimaging acetylcholine (ACh) muscarinic acetylcholine receptor (mAChR) nicotine acetylcholine receptor (nAChR) |
url | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.909961/full |
work_keys_str_mv | AT sofiaeickhoff thebasalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT leonfranzen thebasalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT alexandrakorda thebasalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT helenarogg thebasalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT valerienoelletrulley thebasalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT stefanborgwardt thebasalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT mihaiavram thebasalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT sofiaeickhoff basalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT leonfranzen basalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT alexandrakorda basalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT helenarogg basalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT valerienoelletrulley basalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT stefanborgwardt basalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders AT mihaiavram basalforebraincholinergicnucleiandtheirrelevancetoschizophreniaandotherpsychoticdisorders |